Myles I Brookman, MD
Ophthalmology · Long Beach
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 10 years
- Graduated 2016
Offices
1 location · Azul Vision Inc · 49 clinicians in this group
Looking this up.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Brookman’s office at (562) 938-9945 to ask if they take your plan before you enroll.
California Medical Board record
Licence A169569 · Current
Licensed to practise in California · since 2020 · expires 2028-07-31 · Tel Aviv University, Sackler School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Ophthalmology - Ophthalmology
Original Medicare doctor bills
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Procedures Medicare counted
| Cataract surgery | 1-10 | None |
Procedures year by year
| Procedure | 2021 | 2022 | 2023 |
|---|---|---|---|
| Removal of recurring cataract in lens capsule using a laser | – | 13 | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Year by year
| 2023 | 64 | 110 | 74 | 1.35 | $29,247 | $8,488 |
| 2022 | 119 | 215 | 73 | 1.34 | $75,470 | $21,550 |
| 2021 | 95 | 180 | 73 | 1.37 | $55,736 | $17,175 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 2 services
| Return visit (30+ min) | 23 | $1,469 | $64 |
| Imaging of retina | 14 | $410 | $29 |
2022: 8 services
| Return visit (30+ min) | 48 | $4,374 | $89 |
| Removal of recurring cataract in lens capsule using a laser | 12 | $3,875 | $298 |
| Short return visit (20+ min) | 19 | $1,510 | $76 |
| New patient visit (45+ min) | 11 | $1,453 | $132 |
| Short return visit | 19 | $900 | $36 |
| New patient visit (30+ min) | 12 | $763 | $64 |
| Imaging of retina | 15 | $508 | $34 |
| Imaging of optic nerve | 13 | $354 | $27 |
2021: 4 services
| Return visit (30+ min) | 34 | $3,747 | $101 |
| New patient visit (45+ min) | 29 | $3,472 | $120 |
| Short return visit | 21 | $907 | $39 |
| Imaging of optic nerve | 14 | $416 | $30 |
Medicaid work
$16,935 in 2024
Medicaid paid $16,935 for 2,666 billed services this clinician did in 2024, up to 68 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| XCAPSL CTRC RMVL INSJ IO LENS PROSTH W/O ECP | 14 | $16,935 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 397 | $0 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 402 | $0 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 208 | $0 |
| DETERMINATION REFRACTIVE STATE | 1,178 | $0 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 43 | $0 |
| Fitting of monofocal spectacles | 153 | $0 |
| Fitting of bifocal spectacles | 25 | $0 |
| Short return visit (20+ min) | 15 | $0 |
| Frames, purchases | 231 | $0 |
| 2024 | 2,666 | 10 | 68 | $16,935 |
| 2023 | 1,111 | 12 | 61 | $11,237 |
| 2022 | 16 | 1 | 16 | $83 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 37 | $3,434 |
| Short return visit (20+ min) | 51 | $3,088 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 92 | $1,755 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 61 | $1,520 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 151 | $1,200 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 16 | $240 |
| INTRM OPH EXAM NEW PATIENT | 21 | $0 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 67 | $0 |
| DETERMINATION REFRACTIVE STATE | 404 | $0 |
| Fitting of monofocal spectacles | 63 | $0 |
| Fitting of bifocal spectacles | 14 | $0 |
| Frames, purchases | 134 | $0 |
2022
| New patient visit (45+ min) | 16 | $83 |
Drugs they prescribed that Part D paid
$255,720
Pharmacies billed $255,720 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 3,645) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.
2,323 generic and 1,322 brand-name prescriptions · $255,720 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Lumigan | 86 | $51,985 | $604 |
| Cyclosporine | 34 | $33,791 | $994 |
| Xiidra | 32 | $29,750 | $930 |
| Prednisolone Acetate | 603 | $16,458 | $27 |
| Restasis | 17 | $15,340 | $902 |
See all 21 drugs
| Lumigan | 86 | $51,985 | $604 |
| Cyclosporine | 34 | $33,791 | $994 |
| Xiidra | 32 | $29,750 | $930 |
| Prednisolone Acetate | 603 | $16,458 | $27 |
| Restasis | 17 | $15,340 | $902 |
| Alphagan P | 40 | $13,058 | $326 |
| Rhopressa | 28 | $9,235 | $330 |
| Brimonidine Tartrate-Timolol | 52 | $9,105 | $175 |
| Latanoprost | 660 | $8,494 | $13 |
| Dorzolamide-Timolol | 466 | $7,174 | $15 |
| Rocklatan | 16 | $7,152 | $447 |
| Brimonidine | 168 | $7,002 | $42 |
| Ketorolac Tromethamine | 524 | $6,680 | $13 |
| Moxifloxacin | 306 | $5,302 | $17 |
| Travoprost | 37 | $5,091 | $138 |
| Brinzolamide | 28 | $2,492 | $89 |
| Ofloxacin | 230 | $2,143 | $9 |
| Timolol Maleate | 133 | $2,108 | $16 |
| Dorzolamide | 54 | $935 | $17 |
| Erythromycin | 27 | $306 | $11 |
| Neomycin-Polymyxin-Dexameth | 15 | $178 | $12 |
Year by year
| 2024 | 3,645 | 889 | 0% (0) | 36% | $255,720 |
| 2023 | 3,613 | 937 | 0% (0) | 41% | $356,285 |
| 2022 | 3,759 | 925 | 0% (0) | 40% | $357,274 |
| 2021 | 2,639 | 677 | 0% (0) | 42% | $285,686 |
| 2020 | 322 | 128 | 0% (0) | 39% | $30,769 |
| 2019 | 331 | 96 | 0% (0) | 34% | $18,837 |
| 2018 | 471 | 151 | 0% (0) | 31% | $22,492 |
| 2017 | 184 | 51 | 0% (0) | None | $11,333 |
| 2016 | 28 | None | 0% (0) | None | $1,291 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 23 drugs
| Lumigan | 108 | $53,668 | $497 |
| Restasis | 35 | $51,081 | $1,459 |
| Xiidra | 35 | $41,958 | $1,199 |
| Cyclosporine | 23 | $26,142 | $1,137 |
| Prednisolone Acetate | 618 | $21,830 | $35 |
| Latanoprost | 729 | $19,148 | $26 |
| Alphagan P | 39 | $15,461 | $396 |
| Combigan | 45 | $15,300 | $340 |
| Dorzolamide-Timolol | 427 | $13,903 | $33 |
| Brimonidine Tartrate-Timolol | 39 | $13,881 | $356 |
| Moxifloxacin | 454 | $13,477 | $30 |
| Rhopressa | 17 | $9,688 | $570 |
| Ketorolac Tromethamine | 450 | $9,356 | $21 |
| Brimonidine | 163 | $8,379 | $51 |
| Rocklatan | 20 | $7,024 | $351 |
| Travoprost | 20 | $6,138 | $307 |
| Vyzulta | 14 | $4,671 | $334 |
| Timolol Maleate | 110 | $3,135 | $28 |
| Dorzolamide | 97 | $2,888 | $30 |
| Erythromycin | 24 | $284 | $12 |
| Diclofenac | 20 | $223 | $11 |
| Atropine Sulfate | 11 | $193 | $18 |
| Ofloxacin | 14 | $154 | $11 |
2022: 21 drugs
| Restasis | 46 | $72,087 | $1,567 |
| Lumigan | 114 | $52,862 | $464 |
| Combigan | 57 | $24,873 | $436 |
| Prednisolone Acetate | 645 | $22,909 | $36 |
| Xiidra | 17 | $22,769 | $1,339 |
| Moxifloxacin | 512 | $21,776 | $43 |
| Latanoprost | 763 | $19,609 | $26 |
| Dorzolamide-Timolol | 392 | $13,608 | $35 |
| Alphagan P | 27 | $11,028 | $408 |
| Ketorolac Tromethamine | 515 | $10,392 | $20 |
| Brimonidine Tartrate-Timolol | 30 | $9,726 | $324 |
| Rhopressa | 15 | $7,984 | $532 |
| Travoprost | 24 | $7,221 | $301 |
| Brimonidine | 139 | $6,866 | $49 |
| Rocklatan | 15 | $5,558 | $371 |
| Dorzolamide | 105 | $3,168 | $30 |
| Timolol Maleate | 131 | $2,259 | $17 |
| Azelastine | 13 | $600 | $46 |
| Neomycin-Polymyxin-Dexameth | 26 | $456 | $18 |
| Erythromycin | 32 | $381 | $12 |
| Ofloxacin | 19 | $296 | $16 |
2021: 21 drugs
| Restasis | 59 | $74,327 | $1,260 |
| Lumigan | 76 | $30,551 | $402 |
| Combigan | 56 | $22,232 | $397 |
| Prednisolone Acetate | 438 | $16,543 | $38 |
| Moxifloxacin | 333 | $15,263 | $46 |
| Alphagan P | 43 | $14,583 | $339 |
| Latanoprost | 434 | $12,125 | $28 |
| Xiidra | 19 | $11,546 | $608 |
| Rhopressa | 22 | $10,443 | $475 |
| Rocklatan | 29 | $9,438 | $325 |
| Dorzolamide-Timolol | 221 | $8,433 | $38 |
| Brimonidine | 113 | $7,800 | $69 |
| Ketorolac Tromethamine | 343 | $7,023 | $20 |
| Azopt | 14 | $5,099 | $364 |
| Travoprost | 12 | $3,999 | $333 |
| Timolol Maleate | 137 | $2,491 | $18 |
| Dorzolamide | 74 | $2,239 | $30 |
| Neomycin-Polymyxin-Dexameth | 27 | $424 | $16 |
| Ofloxacin | 27 | $404 | $15 |
| Erythromycin | 26 | $368 | $14 |
| Doxycycline Monohydrate | 11 | $241 | $22 |
2020: 8 drugs
| Travoprost | 13 | $3,265 | $251 |
| Prednisolone Acetate | 39 | $2,493 | $64 |
| Latanoprost | 83 | $1,430 | $17 |
| Dorzolamide-Timolol | 35 | $1,200 | $34 |
| Brimonidine | 46 | $724 | $16 |
| Ketorolac Tromethamine | 12 | $541 | $45 |
| Dorzolamide | 13 | $378 | $29 |
| Ofloxacin | 11 | $158 | $14 |
2019: 7 drugs
| Travatan Z | 28 | $5,812 | $208 |
| Prednisolone Acetate | 33 | $1,966 | $60 |
| Dorzolamide-Timolol | 53 | $1,531 | $29 |
| Latanoprost | 112 | $976 | $9 |
| Ketorolac Tromethamine | 14 | $480 | $34 |
| Brimonidine | 35 | $414 | $12 |
| Timolol Maleate | 12 | $73 | $6 |
2018: 6 drugs
| Travatan Z | 21 | $5,864 | $279 |
| Combigan | 21 | $4,290 | $204 |
| Latanoprost | 218 | $2,248 | $10 |
| Dorzolamide-Timolol | 77 | $1,343 | $17 |
| Prednisolone Acetate | 16 | $1,248 | $78 |
| Brimonidine | 48 | $1,238 | $26 |
2017: 1 drug
| Latanoprost | 41 | $411 | $10 |
Money from drug and device companies
$932 in 2025
| 2025 | 10 | 34 | None | $932 |
| 2024 | 7 | 17 | $400 | $788 |
| 2023 | 7 | 19 | $1,050 | $1,592 |
| 2022 | 7 | 30 | None | $684 |
| 2021 | 6 | 19 | None | $603 |
| 2020 | 2 | 3 | None | $59 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Alcon Vision | Clareon | $347 | 9 payments
|
| Harrow Eye | Vevye | $137 | 10 payments
|
| Johnson & Johnson Surgical Vision | Tecnis Simplicity | $137 | 2 payments
|
| Dompe US | Oxervate | $89 | 4 payments
|
| Abbvie | Lumigan | $83 | 3 payments
|
| Bausch & Lomb Americas | Xiidra | $44 | 2 payments
|
See all 34 published payments
| Harrow Eye | Meals · 2025-12-03 | Vevye | $15 |
| Harrow Eye | Meals · 2025-11-05 | Vevye | $12 |
| Alcon Vision | Meals · 2025-10-31 | Hydrus Microstent | $14 |
| Dompe US | Meals · 2025-10-28 | Oxervate | $25 |
| Dompe US | Meals · 2025-10-22 | Oxervate | $29 |
| Alcon Vision | Meals · 2025-10-15 | Tryptyr | $31 |
| Dompe US | Meals · 2025-10-15 | Oxervate | $17 |
| Harrow Eye | Meals · 2025-09-26 | Vevye | $10 |
| Alcon Vision | Meals · 2025-09-25 | Hydrus Microstent | $19 |
| Harrow Eye | Meals · 2025-09-25 | Vevye | $5 |
| Harrow Eye | Meals · 2025-09-17 | Vevye | $14 |
| Dompe US | Meals · 2025-09-15 | Oxervate | $19 |
| Tarsus Pharmaceuticals | Meals · 2025-09-08 | Xdemvy | $26 |
| Abbvie | Meals · 2025-08-06 | Lumigan | $18 |
| Harrow Eye | Meals · 2025-08-06 | Vevye | $8 |
| Bausch & Lomb Americas | Meals · 2025-07-15 | Xiidra | $23 |
| Amgen | Meals · 2025-06-06 | Tepezza | $21 |
| Johnson & Johnson Surgical Vision | Meals · 2025-05-28 | Tecnis Simplicity | $98 |
| Alcon Vision | Meals · 2025-05-22 | Hydrus Microstent | $25 |
| Harrow Eye | Meals · 2025-05-12 | Vevye | $21 |
| Alcon Vision | Meals · 2025-04-28 | Hydrus Microstent | $22 |
| Bausch & Lomb Americas | Meals · 2025-04-23 | Miebo | $20 |
| Alcon Vision | Meals · 2025-04-19 | Clareon | $169 |
| Alcon Vision | Meals · 2025-04-16 | Rocklatan | $32 |
| Harrow Eye | Meals · 2025-03-25 | Vevye | $18 |
| Sun Pharmaceutical Industries | Meals · 2025-03-17 | Cequa | $22 |
| Harrow Eye | Meals · 2025-03-05 | Vevye | $19 |
| Johnson & Johnson Surgical Vision | Meals · 2025-02-27 | Tecnis Iol | $39 |
| Oyster Point Pharma | Meals · 2025-02-25 | Tyrvaya | $26 |
| Alcon Vision | Meals · 2025-02-11 | Hydrus Microstent | $16 |
| Harrow Eye | Meals · 2025-01-30 | Vevye | $16 |
| Abbvie | Meals · 2025-01-29 | Lumigan | $32 |
| Abbvie | Meals · 2025-01-28 | Lumigan | $34 |
| Alcon Vision | Meals · 2025-01-17 | Hydrus Microstent | $20 |
See earlier years (2024, 2023, 2022, 2021, 2020)
2024: $788
| Alcon Research | None | $400 | 1 payment
|
| Alcon Vision | Hydrus Microstent | $111 | 5 payments
|
| Amgen | Tepezza | $105 | 4 payments
|
| Oyster Point Pharma | Tyrvaya | $75 | 3 payments
|
| Sight Sciences | Omni Surgical System | $46 | 2 payments
|
| Dompe US | Oxervate | $26 | 1 payment
|
| Bausch & Lomb Americas | Miebo | $25 | 1 payment
|
2023: $1,592
| Alcon Research | None | $1,050 | 1 payment
|
| Alcon Vision | Hydrus Microstent | $232 | 4 payments
|
| Horizon Therapeutics plc | Tepezza | $158 | 9 payments
|
| AbbVie | Lumigan | $67 | 2 payments
|
| Sun Pharmaceutical Industries | Cequa | $37 | 1 payment
|
| Novartis Pharmaceuticals | Xiidra | $27 | 1 payment
|
| Johnson & Johnson Surgical Vision | Tecnis Iol | $22 | 1 payment
|
2022: $684
| Horizon Therapeutics plc | Tepezza | $234 | 15 payments
|
| Alcon Vision | Hydrus Microstent | $216 | 5 payments
|
| Sun Pharmaceutical Industries | Cequa | $81 | 3 payments
|
| Abbvie | Vuity | $61 | 3 payments
|
| Allergan | Vuity | $39 | 2 payments
|
| Dompe US | Oxervate | $33 | 1 payment
|
| Novartis Pharmaceuticals | Xiidra | $19 | 1 payment
|
2021: $603
| Ivantis | Hydrus Microstent | $299 | 3 payments
|
| Allergan | Lumigan | $164 | 9 payments
|
| Aerie Pharmaceuticals | Rhopressa | $52 | 3 payments
|
| Horizon Therapeutics plc | Tepezza | $45 | 2 payments
|
| Sun Pharmaceutical Industries | Cequa | $22 | 1 payment
|
| Sight Sciences | Omni(R) Surgical System (US) | $21 | 1 payment
|
2020: $59
| Allergan | Lumigan | $42 | 2 payments
|
| Bausch & Lomb a division of Bausch Health US | Besivance | $17 | 1 payment
|
Professional record
- NPI
- 1063874139
- Licence
- CA A169569California A169569: Current · expires 2028-07-31
- Group
- Azul Vision Inc
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207W00000X (207W00000X)
- Mailing address
- 14726 Ramona Ave Ste 203, Chino, CA, 91710
- NPI first listed
- 2016-03-28
- NPI last updated
- 2025-09-19
- NPI record certified
- 2025-09-19
This is when the NPI record was last certified, not a medical board exam.